medical device manufacturing

BD in Columbus, Neb.
Jan 14, 2026

BD pledges $110M to expand Nebraska syringe manufacturing

BD plans to invest $110 million to upgrade syringe manufacturing in Nebraska, expanding capacity, adding jobs and supporting demand for biologics and GLP-1 drugs.

Smile
Aug 6, 2025

Lura Health partners with Japan’s SCO Group on Asia expansion

The HAX startup will work to expand the reach of its salivary biosensor tech, advancing preventative care and clinical integration.

On Aug. 4, 2025, BD announced plans to invest more than $35 million and add approximately 50 new jobs to expand prefilled flush syringe manufacturing at its Columbus, Neb., facility.
Aug 4, 2025

BD invests $35M to expand syringe plant in Nebraska

The move builds on the Franklin Lakes-based medical technology company's broader commitment to strengthen U.S. health care infrastructure and ensure long-term supply resilience.